 |
市场调查报告书
商品编码
1397195
传输介质市场规模和份额分析（按产品类型、应用、适应症和最终用户）：全球工业需求预测（截至 2030 年）Transport Media Market Size and Share Analysis by Product Type, Application, Indication, End User - Global Industry Demand Forecast to 2030 |
||||||
全球交通媒体市场规模预计到 2023 年将达到 31.013 亿美元，到 2030 年将扩大到 42.106 亿美元，复合年增长率为 4.6%。
该行业的成长是由与病毒性疾病相关的研究和开发的增加、对临床前和诊断测试的需求不断增长以及流感和疱疹等传染病数量的快速增加所推动的。
例如，到 2022 年，全球约有 40 万人将死于流感。 同样，大约 40 亿人患有疱疹。 此外，政府加大力度提高测试套件的接受度也推动了该产业的发展。
按产品类型划分，病毒传输媒体类别将于 2023 年以 35% 的份额引领业界。 这可能是因为 COVID-19 和猴痘等传染病的意外爆发增加了对感染者进行检测和诊断的需求。
此外，在 COVID-19 大流行期间，人们对治疗和诊断的认识不断提高，从而增加了对检测各种其他传染病的相关产品的需求。
有迹象表明，病毒性疾病类别主导了传输介质市场。 此外，这个类别正以十年来最快的速度发展。 这主要是由于流感、猴痘、疱疹、COVID-19、呼吸道合胞病毒、水痘带状疱疹等病毒性疾病发生率急遽上升。
此外，在这些疾病中，流感和 COVID-19 病毒是传染性最强的呼吸道疾病，因此引起了全世界的严重关注。
从最终用户来看，诊断实验室类别在产业中占据最大份额。 这是由于对 COVID-19 的测试和诊断的需求增加。 这推动了诊断实验室的建立并增加了工作量。
北美在该行业占据主导地位。 这是由于诊断测试的激增、传染病研究和开发的增加、医疗保健系统的建立以及大量製药和生物技术公司的存在。
基本上，传染病，尤其是病毒性疾病的激增，是帮助各公司创造收入的主要因素。
由于莱姆病、结核病和 COVID-19 等传染病的盛行率不断上升，亚太地区预计将在过去十年中以最快的复合年增长率增长。
此外，亚太地区（尤其是印度和中国）的传染病患者数量非常多。 因此，多家公司纷纷介入，以满足诊断上庞大的未满足需求。
随着病毒性疾病研究和开发的不断增加以及传染病发病率的上升，传输介质产业可能在未来几年继续发展。
目录
第一章分析范围
第二章分析方法
第 3 章执行摘要
第 4 章市场指标
第五章产业展望
- 市场动态
- 趋势
- 促进因素
- 抑制因素/挑战
- 促进/抑制因子影响分析
- 新型冠状病毒感染 (COVID-19) 的影响
- 波特五力分析
第六章世界市场
- 摘要
- 市场收入：依产品类型划分（2017-2030 年）
- 市场收入：依应用分类（2017-2030 年）
- 市场收入：依指标分类（2017-2030 年）
- 市场收入：以最终用户划分（2017-2030 年）
- 市场收入：按地区划分（2017-2030 年）
第七章北美市场
- 摘要
- 市场收入：依产品类型划分（2017-2030 年）
- 市场收入：依应用分类（2017-2030 年）
- 市场收入：依指标分类（2017-2030 年）
- 市场收入：以最终用户划分（2017-2030 年）
- 市场收入：依国家/地区划分（2017-2030 年）
第8章欧洲市场
第9章亚太市场
第十章中南美市场
第十一章中东非洲市场
第12章美国市场
- 摘要
- 市场收入：依产品类型划分（2017-2030 年）
- 市场收入：依应用分类（2017-2030 年）
- 市场收入：依指标分类（2017-2030 年）
- 市场收入：以最终用户划分（2017-2030 年）
第十三章加拿大市场
第14章德国市场
第十五章法国市场
第十六章英国市场
第十七章义大利市场
第十八章西班牙市场
第十九章日本市场
第20章中国市场
第21章印度市场
第22章澳洲市场
第23章韩国市场
第24章巴西市场
第25章墨西哥市场
第26章沙乌地阿拉伯市场
第27章南非市场
第 28 章阿联酋 (UAE) 市场
第29章竞争态势
- 市场参与者及其产品列表
- 主要公司的竞争基准
- 各大公司的产品基准
- 近期策略发展状况
第30章公司简介
- Thermo Fisher Scientific Inc.
- Puritan Medical Products LLC
- Becton, Dickinson and Company
- COPAN Diagnostics Inc.
- Laboratory Corporation of America Holdings
- HiMedia Laboratories Pvt. Ltd.
- Trinity Biotech plc
- EKF Diagnostics Holdings plc
- Alpha Teknova Inc.
- Vircell S.L.
- Medical Wire & Equipment
- Lucence Health Inc.
- Merck KGaA
- Wuxi AppTec Co. Ltd.
- Bio-Rad Laboratories Inc.
第31章附录
The transport media market is estimated to reach USD 3,101.3 million in 2023, which will increase to USD 4,210.6 million, with a 4.6% compound annual growth rate, by 2030.
The growth of this industry is because of the rising R&D on viral illnesses, increasing need for pre-clinical and diagnostic testing, and the surging occurrence of infectious ailments like influenza and herpes.
For example, in 2022, around 400,000 individuals died from influenza globally. Likewise, approximately 4 billion individuals have herpes. Moreover, the growing count of government initiatives to enhance the acceptance of testing kits is also boosting the industry.
The viral transport media category, based on product type, is leading the industry, with a 35% share, in 2023. This can be because of the unexpected outbreak of infectious ailments like COVID-19 and monkeypox, which boost the requirement for testing and diagnosis among the infected people.
Furthermore, the growing consciousness of treatment and diagnosis during the pandemic of COVID-19 has increased the requirement for related products for detecting various other infections.
The viral diseases category, on the basis of indication, is dominating the transport media market. Furthermore, the category will also advance at the fastest rate during this decade. This can be primarily because of the surging incidence of viral ailments like influenza, monkeypox, herpes, COVID-19, respiratory syncytial virus, and Varicella zoster.
Moreover, among these ailments, the influenza and COVID-19 virus are the most contagious respiratory ailments, therefore, they are a serious cause for worry globally.
The diagnostic laboratories category, based on end user, is the largest contributor to the industry. This is because of the increase in the need for testing as well as diagnosis of COVID-19. This has powered the formation of diagnostic labs and increased their workload.
North America is dominating the industry. This is because of the surging number of diagnostic tests, rising R&D on infectious ailments, well-established healthcare system, and the existence of numerous pharma and biotech businesses.
Basically, the surging occurrence of infectious illnesses, particularly viral ailments, is a main factor that assists in revenue generation for industry players.
APAC will advance at the fastest compound annual growth rate during this decade, because of the rising prevalence of infectious illnesses like Lyme disease, tuberculosis, and COVID-19.
Moreover, the number of people with infectious illnesses is quite high in APAC, particularly in India and China. Therefore, several industry players have arrived to satisfy the vast unmet necessity for diagnosis.
It is because of the increasing research & development in viral ailments and the mounting incidence of infectious illnesses, the transport media industry will continue to progress in the coming years.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product type
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by indication
- 1.4.4. Market size breakdown, by end user
- 1.4.5. Market size breakdown, by region
- 1.4.6. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Product Type (2017-2030)
- 6.3. Market Revenue, by Application (2017-2030)
- 6.4. Market Revenue, by Indication (2017-2030)
- 6.5. Market Revenue, by End User (2017-2030)
- 6.6. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Product Type (2017-2030)
- 7.3. Market Revenue, by Application (2017-2030)
- 7.4. Market Revenue, by Indication (2017-2030)
- 7.5. Market Revenue, by End User (2017-2030)
- 7.6. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Product Type (2017-2030)
- 8.3. Market Revenue, by Application (2017-2030)
- 8.4. Market Revenue, by Indication (2017-2030)
- 8.5. Market Revenue, by End User (2017-2030)
- 8.6. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Product Type (2017-2030)
- 9.3. Market Revenue, by Application (2017-2030)
- 9.4. Market Revenue, by Indication (2017-2030)
- 9.5. Market Revenue, by End User (2017-2030)
- 9.6. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Product Type (2017-2030)
- 10.3. Market Revenue, by Application (2017-2030)
- 10.4. Market Revenue, by Indication (2017-2030)
- 10.5. Market Revenue, by End User (2017-2030)
- 10.6. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Product Type (2017-2030)
- 11.3. Market Revenue, by Application (2017-2030)
- 11.4. Market Revenue, by Indication (2017-2030)
- 11.5. Market Revenue, by End User (2017-2030)
- 11.6. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Product Type (2017-2030)
- 12.3. Market Revenue, by Application (2017-2030)
- 12.4. Market Revenue, by Indication (2017-2030)
- 12.5. Market Revenue, by End User (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Product Type (2017-2030)
- 13.3. Market Revenue, by Application (2017-2030)
- 13.4. Market Revenue, by Indication (2017-2030)
- 13.5. Market Revenue, by End User (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Product Type (2017-2030)
- 14.3. Market Revenue, by Application (2017-2030)
- 14.4. Market Revenue, by Indication (2017-2030)
- 14.5. Market Revenue, by End User (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Product Type (2017-2030)
- 15.3. Market Revenue, by Application (2017-2030)
- 15.4. Market Revenue, by Indication (2017-2030)
- 15.5. Market Revenue, by End User (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Product Type (2017-2030)
- 16.3. Market Revenue, by Application (2017-2030)
- 16.4. Market Revenue, by Indication (2017-2030)
- 16.5. Market Revenue, by End User (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Product Type (2017-2030)
- 17.3. Market Revenue, by Application (2017-2030)
- 17.4. Market Revenue, by Indication (2017-2030)
- 17.5. Market Revenue, by End User (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Product Type (2017-2030)
- 18.3. Market Revenue, by Application (2017-2030)
- 18.4. Market Revenue, by Indication (2017-2030)
- 18.5. Market Revenue, by End User (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Product Type (2017-2030)
- 19.3. Market Revenue, by Application (2017-2030)
- 19.4. Market Revenue, by Indication (2017-2030)
- 19.5. Market Revenue, by End User (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Product Type (2017-2030)
- 20.3. Market Revenue, by Application (2017-2030)
- 20.4. Market Revenue, by Indication (2017-2030)
- 20.5. Market Revenue, by End User (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Product Type (2017-2030)
- 21.3. Market Revenue, by Application (2017-2030)
- 21.4. Market Revenue, by Indication (2017-2030)
- 21.5. Market Revenue, by End User (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Product Type (2017-2030)
- 22.3. Market Revenue, by Application (2017-2030)
- 22.4. Market Revenue, by Indication (2017-2030)
- 22.5. Market Revenue, by End User (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Product Type (2017-2030)
- 23.3. Market Revenue, by Application (2017-2030)
- 23.4. Market Revenue, by Indication (2017-2030)
- 23.5. Market Revenue, by End User (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Product Type (2017-2030)
- 24.3. Market Revenue, by Application (2017-2030)
- 24.4. Market Revenue, by Indication (2017-2030)
- 24.5. Market Revenue, by End User (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Product Type (2017-2030)
- 25.3. Market Revenue, by Application (2017-2030)
- 25.4. Market Revenue, by Indication (2017-2030)
- 25.5. Market Revenue, by End User (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Product Type (2017-2030)
- 26.3. Market Revenue, by Application (2017-2030)
- 26.4. Market Revenue, by Indication (2017-2030)
- 26.5. Market Revenue, by End User (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Product Type (2017-2030)
- 27.3. Market Revenue, by Application (2017-2030)
- 27.4. Market Revenue, by Indication (2017-2030)
- 27.5. Market Revenue, by End User (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Product Type (2017-2030)
- 28.3. Market Revenue, by Application (2017-2030)
- 28.4. Market Revenue, by Indication (2017-2030)
- 28.5. Market Revenue, by End User (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Thermo Fisher Scientific Inc.
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Puritan Medical Products LLC
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.3. Becton, Dickinson and Company
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. COPAN Diagnostics Inc.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.5. Laboratory Corporation of America Holdings
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. HiMedia Laboratories Pvt. Ltd.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.7. Trinity Biotech plc
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. EKF Diagnostics Holdings plc
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. Alpha Teknova Inc.
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. Vircell S.L.
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.11. Medical Wire & Equipment
- 30.11.1. Business overview
- 30.11.2. Product and service offerings
- 30.12. Lucence Health Inc.
- 30.12.1. Business overview
- 30.12.2. Product and service offerings
- 30.13. Merck KGaA
- 30.13.1. Business overview
- 30.13.2. Product and service offerings
- 30.13.3. Key financial summary
- 30.14. Wuxi AppTec Co. Ltd.
- 30.14.1. Business overview
- 30.14.2. Product and service offerings
- 30.14.3. Key financial summary
- 30.15. Bio-Rad Laboratories Inc.
- 30.15.1. Business overview
- 30.15.2. Product and service offerings
- 30.15.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
